Logos Global Management LP
Insider CIK 1792126 · NVUS 10% owner · DYN 10% owner · VERV 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-22 | 4,104,416 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-22 | 443,265 | — | $0 | 443,265 | SEC↗ |
| VERV Verve Therapeutics, Inc. | P Buy | 2021-06-21 | 2021-06-22 | 370,000 | $19.00 | $7.03M | 370,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | S Sale | 2020-10-30 | 2020-11-06 | 12,942 | $26.64 | $344.8K | 187,058 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | P Buy | 2020-10-30 | 2020-11-06 | 15,000 | $26.17 | $392.6K | 214,973 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | S Sale | 2020-10-30 | 2020-11-06 | 27 | $27.02 | $730 | 199,973 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | P Buy | 2020-10-30 | 2020-11-06 | 12,942 | $25.88 | $334.9K | 200,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | P Buy | 2020-10-30 | 2020-11-06 | 9,098 | $25.55 | $232.5K | 224,071 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | P Buy | 2020-10-30 | 2020-11-06 | 15,000 | $26.48 | $397.2K | 200,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | P Buy | 2020-10-30 | 2020-11-06 | 4,000 | $25.97 | $103.9K | 185,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | P Buy | 2020-10-30 | 2020-11-06 | 31,000 | $24.53 | $760.4K | 181,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | P Buy | 2020-10-30 | 2020-11-06 | 5,000 | $24.03 | $120.2K | 150,000 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 2,668,089 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 804,392 | — | $0 | 804,392 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | P Buy | 2020-09-21 | 2020-09-23 | 700,000 | $19.00 | $13.30M | 1,504,392 | SEC↗ |